| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Gastroenterology and Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710
Rat hepatocytes in primary culture are stimulated to synthesize DNA by high-molecular-weight fractions from rat serum. This activity has been previously given the name hepatopoietin A (HPTA). HPTA, with an apparent molecular weight of 150,000 to 250,000, stimulated the incorporation of [3H]thymidine into DNA, quantitated by autoradiography as percentage of nuclear labeling. Properties of HPTA include: sensitivity to heat; stability in minimal essential media at 4°C; in lyophilized form; or in 25% glycerol at -20°C; and instability at 4°C in isotonic buffer. Trypsin digestion of HPTA resulted in an increase in biological activity. Both the trypsinized and native forms of this activity were not inhibited by antiserum against mouse epidermal growth factor in this bioassay. Treatment of HPTA with trypsin resulted in a shift of its apparent molecular weight on a Sephadex G-50 column to <6000. This trypsinized HPTA activity did not comigrate with 125I-labeled epidermal growth factor on the same column. These results demonstrate that HPTA exists in normal serum as a large precursor to a more active moiety, generated by proteolytic cleavage, which is not identical to epidermal growth factor. Fractions from human serum and plasma of molecular weight similar to that of HPTA have also been shown to stimulate DNA synthesis in rat hepatocytes.
1 Supported by NIH Grant CA 35373.
2 Recipient of National Research Service Award AM 071669.
3 To whom requests for reprints should be addressed, at Department of Pathology, Box 3432, Duke University Medical Center, Durham, NC 27710.
Received 10/ 9/84. Revised 1/24/85. Accepted 3/ 8/85.
This article has been cited by other articles:
![]() |
A. M. Hopkins, M. Bruewer, G. T. Brown, A. A. Pineda, J. J. Ha, L. M. Winfree, S. V. Walsh, B. A. Babbin, and A. Nusrat Epithelial cell spreading induced by hepatocyte growth factor influences paxillin protein synthesis and posttranslational modification Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G886 - G898. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Iida, K. Johkura, R. Teng, S. Kubota, L. Cui, X. Zhao, N. Ogiwara, Y. Okouchi, K. Asanuma, J. Nakayama, et al. Immunohistochemical Localization of Hepatocyte Growth Factor Activator (HGFA) in Developing Mouse Liver Tissues: Heterogeneous Distribution of HGFA Protein J. Histochem. Cytochem., September 1, 2003; 51(9): 1139 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tamatani, K. Hattori, A. Iyer, K. Tamatani, and R. Oyasu Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro Carcinogenesis, June 1, 1999; 20(6): 957 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Schaper and T. Kubin Is Hepatocyte Growth Factor a Protein With Cardioprotective Activity in the Ischemic Heart? Circulation, June 3, 1997; 95(11): 2471 - 2472. [Full Text] |
||||
![]() |
P Clark Modulation of scatter factor/hepatocyte growth factor activity by cell-substratum adhesion J. Cell Sci., January 5, 1994; 107(5): 1265 - 1275. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |